Masthead.
- Published in:
- Drug Development Research, 1995, v. 35, n. 2, p. fmi, doi. 10.1002/ddr.430350201
- Publication type:
- Article
Works matching IS 02724391 AND DT 1995 AND VI 35 AND IP 2
Results: 7
1
2
Doses of acetyl salicylic acid and morphine in combination which provided either maximal levels of analgesia or the highest potentiation effect in the rat.
- Published in:
- Drug Development Research, 1995, v. 35, n. 2, p. 94, doi. 10.1002/ddr.430350205
- By:
- Publication type:
- Article
3
Facilitating effects of SR 57746A on short-term memory in an operant delayed alternation task in aged rats.
- Published in:
- Drug Development Research, 1995, v. 35, n. 2, p. 83, doi. 10.1002/ddr.430350204
- By:
- Publication type:
- Article
4
Antidiabetic agent pioglitazone increases insulin receptors on 3T3-L1 adipocytes.
- Published in:
- Drug Development Research, 1995, v. 35, n. 2, p. 69, doi. 10.1002/ddr.430350203
- By:
- Publication type:
- Article
5
Burger's medicinal chemistry and drug discovery. 5th Edition. Volume 1: Principles and Practice. Manfred E. Wolff (ed.), Wiley-Interscience, New York, 1995, xi + 1,064 pages, $195.
- Published in:
- Drug Development Research, 1995, v. 35, n. 2, p. 116, doi. 10.1002/ddr.430350207
- By:
- Publication type:
- Article
6
Cellular electrophysiological effects of MS-551, a new class III antiarrhythmic agent.
- Published in:
- Drug Development Research, 1995, v. 35, n. 2, p. 61, doi. 10.1002/ddr.430350202
- By:
- Publication type:
- Article
7
Canine plasma concentration-cardiovascular effect relationships for bidisomide, a new antiarrhythmic drug, and disopyramide, cibenzoline, and propafenone.
- Published in:
- Drug Development Research, 1995, v. 35, n. 2, p. 102, doi. 10.1002/ddr.430350206
- By:
- Publication type:
- Article